Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  199.32
+0.53 (0.27%)
AAPL  262.36
+6.58 (2.57%)
AMD  202.14
-5.18 (-2.50%)
BAC  52.70
+0.15 (0.29%)
GOOG  301.22
-4.80 (-1.57%)
META  637.94
-1.83 (-0.29%)
MSFT  395.80
-5.52 (-1.38%)
NVDA  184.45
+1.64 (0.90%)
ORCL  153.53
-6.61 (-4.13%)
TSLA  405.64
-11.80 (-2.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.